Estrogen and Enalapril attenuate the Development of Right Ventricular Hypertrophy induced by Monocrotaline in Ovariectomized Rats

Journal of Korean Medical Science

Volumn 18, Issue 5, 2003, Pages 641-648

  Ahn, Byung Hoon ^b   Park, Hwan Ki ^a   Cho, Hyun Gug ^c   Lee, Hae Ahm ^a   Lee, Young Man ^d   Yang, Eun Kyoung ^a   Lee, Won Jung ^a  

^a Kyungpook National University School of Medicine   (South Korea)

^b Keimyung University   (South Korea)

^c Kyungwoon University   (South Korea)

^d Catholic University of Daegu   (South Korea)

Author keywords

Cardiac Remodeling, Ventricular; Hypertension, Pulmonary; Renin Angiotensin System; Sex Difference

Indexed keywords

ANGIOTENSIN; ENALAPRIL; ENDOTHELIN 1; ESTRADIOL; MESSENGER RNA; MONOCROTALINE; RENIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFECT; ESTROGEN ACTIVITY; FEMALE; GENE EXPRESSION; HEART INJURY; HEART RIGHT VENTRICLE HYPERTROPHY; HISTOPATHOLOGY; LUNG STRUCTURE; MALE; NONHUMAN; OVARIECTOMY; OVARY FUNCTION; PULMONARY HYPERTENSION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; ULTRASTRUCTURE;

EID: 0346964663     PISSN: 10118934     EISSN: None     Source Type: Journal    
DOI: 10.3346/jkms.2003.18.5.641     Document Type: Article

References (42)

1. Collins P, Beale CM. Cardiovascular disease in women. In: The cardioprotective role of HRT: a clinical update. New York: The Parthenon Publishing Groups 1996; 9-11.
2. Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med 1991; 20: 47-63.
3. Crofton JT, Ota M, Share L. Role of vasopressin, the renin-angiotensin system and sex in Dahl salt-sensitive hypertension. J Hypertens 1993; 11: 1031-8.
4. Sawada A, Kuriyama T, Sugita T, Watanabe S. Monocrotaline-induced pulmonary hypertension with special reference to the influence of dose, age and sex. Nihon Kyobu Shikkan Gakkai Zasshi 1985; 23: 578-83.
5. Okuniewski R, Davis EA, Jarrott B, Widdop RE. A comparison of the development of renal hypertension in male and female rats. Clin Sci (Lond) 1998; 95: 445-51.
6. Swynghedauw B. Molecular mechanisms of myocardial remodeling. Physiol Rev 1999; 79: 215-62.
7. Inagami T. The centenial of renin discovery. Hypertension 1988; 32: 953-7.
8. Yamazaki T, Komuro I, Yazaki Y. Role of the renin-angiotensin system in cardiac hypertrophy. Am J Cardiol 1999; 83: 53H-7.
9. Studer R, Reinecke H, Muller B, Holtz J, Just H, Drexler H. Increased angiotensin-I converting enzyme gene expression in the failing human heart: quantification by competitive RNA polymerase chain reaction. J Clin Invest 1994; 94: 301-10.
10. Johnson C, Fabris B, Yoshida K. The cardiac renin-angiotensin system in heart failure. Am Heart J 1993; 126: 756-60.
11. Schunkert H, Dzau VJ, Tang SS, Hirsch AT, Apstein CS, Lorell BH. Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy. Effects on coronary resistance, contractility and relaxation. J Clin Invest 1990; 86: 1913-20.
12. Kramer CM, Ferrari VA, Rogers WJ, Theobald TM, Nance ML, Axel L, Reichek N. Angiotensin-converting enzyme inhibition limits dysfunction in adjacent noninfarcted regions during left ventricular remodeling. J Am Coll Cardiol 1996; 27: 211-7.
13. Pfeffer MA, Lamas GA, Vaughan DE, Parisi AF, Braunwald E. Effect of captopril on progressive ventricular dilation after anterior myocardial infarction. N Engl J Med 1988; 319: 80-6.
14. Kiyatake K, Kakusaka I, Kasahara Y, Qi TM, Suzuki A, Nakano K, Kaneko N, Kitada M, Kuriyama T. [Relationship between the converting ability of liver microsomes and monocrotaline-induced pulmonary hypertension in male, female and castrated male rats.] Nihon Kyobu Shikkan Gakkai Zasshi 1994; 32: 125-9.
15. 1, endothelin-1 and nitric oxide synthase in right-ventricular hypertrophy. Pharmacol Res 2001; 43: 265-73.
16. Chomczinski P, Sacchi N. Single-step of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-9.
17. Jo H, Yang EK, Lee WJ, Park KY, Kim HJ, Park JS. Gene expression of central and peripheral renin-angiotensin system components upon dietary sodium intake in rats. Regul Pept 1996; 67: 115-21.
18. Farhat MY, Lavigne MC, Ramwell PW. The vascular protective effects of estrogen. FASEB J 1996; 10: 615-24.
19. Karas RH, Patterson BL, Mendelsohn ME. Human vascular smooth muscle cells contain functional estrogen receptor. Circulation 1994; 89: 1943-50.
20. Grohé C, Kahlert S, Löbbert K, Vetter H. Expression of oestrogen receptor alpha and beta in rat heart: role of local oestrogen synthesis. J Endocrinol 1998; 156: R1-7.
21. cp rats. J Mol Cell Cardiol 1999; 31: 1527-37.
22. Schaible T, Malhotra A, Ciambrone G, Scheuer J. The effects of gonadectomy on left ventricular function and cardiac contractile proteins in male and female rats. Circ Res 1984; 54: 38-49.
23. Kolodgie FD, Farb A, Litovsky SH, Narula J, Jeffers LA, Lee SJ, Virmani R. Myocardial protection of contractile function after global ischemia by physiologic estrogen replacement in the ovariectomized rat. J Mol Cell Cardiol 1997; 29: 2403-14.
24. Fraser H, Davidge ST, Clanachan AS. Enhancement of post-ischemia myocardial function by chronic 17β-estradiol treatment: role of alterations in glucose metabolism. J Mol Cell Cardiol 1999; 31: 1539-49.
25. van Eickels M, Grohe C, Cleutjens JPM, Janssen BJ, Wellens HJJ, Doevendans PA. 17β-estradiol attenuates the development of pressure-overload hypertrophy. Circulation 2001; 104: 1419-23.
26. Resta TC, Kanagy LN, Walker BR. Estradiol-induced attenuation of pulmonary hypertension is not associated with altered eNOS expression. Am J Physiol Lung Cell Mol Physiol 2001; 280: L88-97.
27. Farhat MY, Chen MF, Bhatti T, Iqbal A, Cathapermal S, Ramwell PW. Protection by oestradiol against the development of cardiovascular changes associated with monocrotaline pulmonary hypertension in rats. Br J Pharmacol 1993; 110: 719-23.
28. Earley S, Resta TC. Estradiol attenuates hypoxia-induced pulmonary endothelin-1 gene expression. Am J Physiol Lung Cell Mol Physiol 2002; 283: L86-93.
29. Mukundan H, Resta TC, Kanagy NL. 17β-estradiol decreases hypoxic induction of erythropoietin gene exprepssion. Am J Physiol Regul Integr Comp Physiol 2002; 283: R496-504.
30. Massaro GD, Mortola P, Massaro D. Estrogen modulates the dimensions of the lung's gas-exchange surface area and alveoli in female rats. Am J Physiol 1996; 270: L110-4.
31. Dubey RK, Gillespie DG, Jackson EK, Keller PJ. 17Beta-estradiol, its metabolites, and progesterone inhibit cardiac fibroblast growth. Hypertension 1998; 31: 522-8.
32. Kentera D, Susic D, Cvetkovic A, Djordjevic G. Effects of SQ 14.225, an orally active inhibitor of angiotensin-converting enzyme, on hypoxic pulmonary hypertension and right ventricular hypertrophy in rats. Basic Res Cardiol 1981; 76: 344-51.
33. Pelouch V, Kolar F, Ost'adal B, Milerova M, Cihak R, Widimsky J. Regression of chronic hypoxia-induced pulmonary hypertension, right ventricular hypertension, and fibrosis: effect of enalapril. Cardiovasc Drugs Ther 1997; 11: 177-85.
34. Kramer C M, Ferrari V A, Rogers W J, Theobald T M, Nance M L, Axel L, Reichek N. Angiotensin-converting enzyme inhibition limits dysfunction in adjacent noninfarcted regions during left ventricular remodeling. J Am Coll Cardiol 1996; 27: 211-7.
35. Pfeffer MA, Lamas GA, Vaughan DE, Parisi AF, Braunwald E. Effect of captopril on progressive ventricular dilation after anterior myocardial infarction. N Engl J Med 1988; 319: 80-6.
36. Morrell NW, Danilov SM, Satyan KB, Morris KG, Stenmark KR. Right ventricular angiotensin converting enzyme activity and expression is increased during hypoxic pulmonary hypertension. Cardiovasc Res 1997; 34: 393-403.
37. Adamy C, Oliviero P, Eddahibi S, Rappaport L, Samuel JL, Teiger E, Chassagne C. Cardiac modulations of ANG II receptor expression in rats with hypoxic pulmonary hypertension. Am J Physiol Heart Circ Physiol 2002; 283: H733-40.
38. Kanno S, Wu YJ, Lee PC, Billiar TR, Ho C. Angiotensin-converting enzyme inhibitor preserves p21 and endothelial nitric oxide synthase expression in monocrotaline-induced pulmonary arterial hypertension in rats. Circulation 2001; 104: 945-50.
39. Border WA, Nobel NA. Transforming growth factor-β in tissue fibrosis. N Engl J Med 1994; 331: 1286-92.
40. MacLellan WR, Brand T, Schneider MD. Transforming growth factor-beta in cardiac ontogeny and adaptation. Circ Res 1993; 73: 783-91.
41. Miyauchi T, Yorikane R, Sakai S, Sakurai T, Okada M, Nishikibe M, Yano M, Yamaguchi I, Sugishita Y, Goto K. Contribution of endogenous endothelin-1 to the progression of cardiopulmonary alterations in rats with monocrotaline- induced pulmonary hypertension. Circ Res 1993; 73: 887-97.
42. A receptor angatonist (+)-(S)-2-(4,6-dimethyoxy-pyrimidine- 2-yloxy)-3-methoxy-3,3-diphenyl-propionic acid (LU 135252) prevents the development of pulmonary hypertension and endothelial metabolic dysfunction in monocrotaline-treated rats. J Pharmacol Exp Therap 1997; 282: 1312-8.